ORDER
REPRINTS
3078
DA CONCEICAO RODRIGUES AND AGUIAR
recorded with a Nicolet Magna IR 750. All melting points are uncorrected
and measured in a Fisher-Johns apparatus. TLC was carried out on pre-
coated Merck silica gel aluminum plates 60 F254. Column chromatography
was performed using silica gel 60 (230–240 mesh).
General Procedure
To a solution of trichloroisocyanuric acid (0.198 g–0.85 mmol),
0.15 mL of pyridine, and 15 mL de CH2Cl2 are added the aldoxime (1)
(mp 130–131ꢀC) in 5 mL of CH2Cl2. The mixture was stirred for about
24 h as RT and the alkenes in the ratios 1:1, 2:1 or 3:1 were added followed
by triethylamine (0.40 mL–2.80 mmol). An exoterm reaction ensued and the
mixture became dark yellow. After stirring for further 24 h at RT, the mix-
ture was diluted to 50 mL with CH2Cl2 and washed with aqueous saturated
NaHCO3 solution (2 ꢁ 70 mL), dried over MgSO4 and concentrated to dry-
ness under vacuum. Purification by flash chromatography (20 g of silica gel)
using ethyl acetate–hexane (1 : 2) gave the respectives 4,5-dihydroisoxazoles
in 30–60%.
3-(3-methoxy-4-(phenylmethoxy)-5-cyano-4,5-dihydroisoxazole
(5):
(mp 104–105ꢀC) HRMS (m/z-%) (Mþ ¼ 308.1171-100%); IR (neat, cmꢂ1
)
1681 (C¼N), 1600 (C¼C), 1270 (C-O-C), 13C NMR (75 MHz, CDCl3, APT)
d 155.9 (C-3), 150.5 (C-9), 149.6 (C-8), 136.1 (C-13), 128.5 (C-14/18), 127.9
(C-16), 127.1 (C-15/17), 120.6 (C-11), 120.1 (C-6), 117.1 (CN), 112.6 (C-10),
109.1 (C-7), 70.5 (C-12), 66.3 (C-5), 55.8 (C-19), 40.9 (C-4). 1H NMR
(300 MHz, CDCl3) d 3.68 (m, H-4), 3.91 (s, H-19), 5.20 (s, H-12), 5.31
3
3
3
(dd, JH5-4A ¼ 9.9 Hz, JH5-4B ¼ 6.8 Hz, H-5), 6.88 (d, JH-H ¼ 8.3 Hz,
3
4
H-10), 6.97 (dd, JH-H ¼ 8.3 Hz, JH-H ¼ 2.0 Hz, H-11), 7.40 (m, H-7,
14, 15, 16, 17, 18).
3-(3-methoxy-4-(phenylmethoxy)-5-bromomethane-4,5-dihydroisoxa-
zole (6): (mp 93–94ꢀC) HRMS (m/z-%) (Mþ ¼ 375.0484 – 100%); IR (neat,
cmꢂ1) 3070 (¼C-H), 1599 (C¼C), 1263 (C-O-C); 13C NMR (75 MHz,
CDCl3) d 155.6 (C-3), 150.0 (C-9), 149.6 (C-8), 136.4 (C-13), 128.5 (C-14/
18), 127.9 (C-16), 127.1 (C-15/17), 122.0 (C-11), 120.2 (C-6), 112.8 (C-10),
109.0 (C-7), 79.4 (C-5), 70.6 (C-12), 55.9 (C-19), 39.5 (C-4), 33.1 (CH2Br);
1H NMR (300 MHz, CDCl3) d 3.42 (m, H4A,4B and CH2Br), 3.92 (s, H-19),
3
4.97 (m, H-5), 5.20 (s, H-12), 6.86 (d, JH-H ¼ 8.1 Hz, H-10), 6.97 (dd,
4
3JH-H ¼ 8.1 Hz, JH-H ¼ 2.1 Hz, H-11), 7.37 (m, H-7, 14, 15, 16, 17, 18).
3-(3-methoxy-4-(phenylmethoxy)-5-ethoxy-4,5-dihydroisoxazole (7):
)
(mp 80–81ꢀC) HRMS (m/z-%) (Mþ ¼ 327.1435-100%); IR (neat, cmꢂ1
2974 (CH3as), 2937 (CH2as), 2871 (CH3s), 1600 (C¼C), 1265 (C-O-C);
13C NMR (50 MHz, CDCl3 PENDANT) d 156.9 (C-3), 150.2 (C-9), 149.8